Co-amilofruse
From Wikipedia, the free encyclopedia
|
Co-amilofruse
|
|
| Combination of | |
| Amiloride | Potassium-sparing diuretic |
| Frusemide | Loop diuretic |
| Identifiers | |
| CAS number | ? |
| ATC code | C03 |
| PubChem | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Co-amilofruse (BAN) is a non-proprietary name used to denote a combination of amiloride and the formerly named frusemide (now the INN termed furosemide). Co-amilofruse in the treatment of fluid retension (oedema), either in the legs (peripheral edema) or on the lungs (pulmonary oedema). The stronger furosemide loop diuretic has a tendency to cause low potassium levels (hypokalaemia) that may be prevented by the potassium-sparing effects of amiloride.
[edit] Formulation
Two strengths of co-amilofruse are available:
- 2.5 mg amiloride with 20 mg furosemide, BAN of Co-amilofruse 2.5/20 (brand name Frumil LS)
- 5 mg amiloride with 40 mg furosemide, BAN of Co-amilofruse 5/4-0 (brand name Frumil)
